About Interlace Medical
Interlace Medical is a Healthcare company based in Framingham (United States) founded in 2006, and was acquired by Hologic in January 2011. Gynecological devices for office-based procedures are designed and developed. Interlace Medical has raised $32.5 million across 3 funding rounds from investors including Hologic, New Leaf Venture Partners and Tekla Capital Management. Its focus areas include Life Sciences, Women Health, Medical Devices and Screening Devices. Its legal entity is Interlace Medical, Inc. Its competitors include Gynesonics, Channel Medsystems and Minerva Surgical; 3 of its 3 listed competitors have raised funding.
Company details
Interlace Medical was founded in 2006 in Framingham, United States, within the medical devices sector focused on gynecology. Devices are developed for interventional gynecologists to enable office-based treatments for conditions such as submucosal fibroids and polyps, reducing the need for operating room surgeries. Key products include the MyoSure hysteroscopic tissue removal system. The company was acquired by Hologic in January 2011.
- Headquarters Framingham, United States
- Stage Acquired
- SectorsHealthcare
- Website interlacemedical.com
- Social LinkedIn
- Acquired by Hologic (Jan 2011)
- Legal Name Interlace Medical, Inc
Funding Insights of Interlace Medical
Interlace Medical has successfully raised a total of $32.5M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $20.5 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32.5M
- Total Rounds 3
- Last Round Series C — $20.5M
- First Round $5M
(May 2007)
- Investors Count 6
All 3 funding rounds of Interlace Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2009 | $20.5M | Series C | – | Baird Capital | |
| Jul 2008 | $7M | Series B | – | – | |
| May 2007 | $5M | Series A | – | – |
7 investors in total: 7 institutional.
Investors in Interlace Medical
Interlace Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, New Leaf Venture Partners and Tekla Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm investing in expansion stage tech and life sciences companies in the US | hlmvp.com | Waltham, United States | ||
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
A healthcare-focused investment firm supporting innovative company growth. | aperturevp.com | |||
| spraypartners.com | ||||
Investment advisory services are provided to financial clients. | 1986 | teklacap.com | Boston, United States | |
Diagnostic and surgical products for women's healthcare are provided. | 1985 | hologic.com | Marlborough, United States |
Investor details for Interlace Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Interlace Medical
4 dated milestones of Interlace Medical across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Interlace Medical is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series C, of $20.5M.
- Exit Acquired by Hologic.
Competitors of Interlace Medical
Interlace Medical has 3 listed competitors in our database, 3 of them funded. They include Gynesonics, Channel Medsystems and Minerva Surgical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gynesonics.com | 2005 | Redwood, United States | $282.54M | 92 | A minimally invasive ablation system for uterine fibroids is developed. | |
| channelmedsystems.com | 2009 | San Francisco, United States | $47.67M | 37 | Cryothermic technology for endometrial ablation to control heavy bleeding | |
| minervasurgical.com | 2008 | Redwood, United States | $135.1M | 155 | Minerva Surgical is focused on uterine health solutions. |
Detailed competitors of Interlace Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Interlace Medical (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Interlace Medical
Complete news archive for Interlace Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Interlace Medical
Interlace Medical was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Interlace Medical is headquartered in Framingham, United States. It is registered at Framingham, Massachusetts, United States.
Interlace Medical is a funded company, having raised a total of $32.5M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on May 2007.
Interlace Medical was founded in 2006 in Framingham, United States, within the medical devices sector focused on gynecology. Devices are developed for interventional gynecologists to enable office-based treatments for conditions such as submucosal fibroids and polyps, reducing the need for operating room surgeries. Key products include the MyoSure hysteroscopic tissue removal system. The company was acquired by Hologic in January 2011.
Interlace Medical's top competitors include Gynesonics, Channel Medsystems and Minerva Surgical.
Interlace Medical has 7 investors. Key investors include Hologic, New Leaf Venture Partners, Tekla Capital Management, HLM Venture Partners, and Baird Capital.
Interlace Medical operates through Interlace Medical, Inc.
Yes. Interlace Medical was acquired by Hologic in January 2011.